Decreased motor coordination deficits in <i>Cln6^nclf</i> mice. by Jeremy P. Morgan (479017)

Oral administration of TVSE decreases angiogenesis in 4T1 tumors in BALB/c mice. by Hyun Sook Lee (8039876)

<i>In vivo</i> sibutramine administration decreases the tyramine-induced tension of epididymal cauda duct. by Cibele S. Borges (420750)

MMP-9 expression is decreased in LV-shRNA-ADAMTS-1 transduced vessels. by Evelyn C. Nieves Torres (551495)

Poly I:C stimulation significantly decreased the number of lysozyme positive cells in enteroids. by Julie M. Davies (412514)

HIF-1α knockdown decreases tumor angiogenesis at sites of bone metastases in mice. by Lauren K. Dunn (260121)

Bay 61–3606 sensitizes MCF-7 cells to TRAIL by decreasing Mcl-1. by So-Young Kim (562174)

<i>Syx5</i> suppression in <i>Drosophila</i> S2 cells decreases copper accumulation. by Melanie Norgate (234832)

Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

Ethanol decreases hepatic ATP and causes modest liver injury: protection by Alda-1. by Zhi Zhong (314411)

Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

“…<p><b>(A)</b> Kaplan-Meier survival curve. Tamoxifen was given by gavage for 6 days to mice with the genotype <i>Mll1</i>^{<i>FC/+; Vil-Cre-ERT2/+</i>} (n = 12) and <i>Mll1</i>^{<i>FC/FC; RC/+</i>} (n = 18). …”

Silencing of Rac1 and IQGAP1 decreases HPAEC migration in an <i>in vitro</i> scratch assay. by Evgeny V. Berdyshev (307465)

Simultaneous ablation of Syt1 and Syt7 decreases the RRP size at excitatory synapses. by Taulant Bacaj (803415)

“…<p><b>A & B.</b> Ablation of both Syt1 and Syt7 in hippocampal neurons decreases the RRP size at excitatory synapses in a manner that is rescued by WT Syt7 (Syt7^WT) or Syt1 (Syt1^WT) but not by mutant Syt7 (Syt7^C2A*^B*) or Syt1 (Syt1^C2A*^B*) with altered top-loop sequences containing the Ca²⁺-binding sequences (A, Syt7 rescue; B, Syt1 rescue). …”

KCl treatment increases Elk1 SUMOylation and decreases katanin-p60 expression. by Ece Selçuk (436963)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

Praziquantel treatment does not alter SmLy6A and SmLy6B IgG₁ age distribution profiles, but does decrease antigen-specific IgG₁ reactivity. by Iain W. Chalmers (173561)

Loss of Runx1 in <i>mdx</i> mice decreases muscle mass, muscle strength and lifespan. by Kfir Baruch Umansky (783699)

Blockade of kinin B₁R in the chronic disease phase decreased the clinical symptoms and neuroinflammation in the EAE model. by Rafael C. Dutra (205755)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”

Reduction of OPL and decreased number of horizontal cells in P18 Oc-deficient mice. by Michaela Kreplova (9239560)